IMMUNATE S/D subst sèche 250 UI cum solv flac

7680527150162 Pharmacode 2998296 CH-52715 B02BD06 06.01.1.
IMMUNATE S/D subst sèche 250 UI cum solv flac
IMMUNATE S/D subst sèche 250 UI cum solv flac
IMMUNATE S/D subst sèche 250 UI cum solv flac
1 / 3
google

Details

GTIN
7680527150162
Pharmacode
2998296
Product number
5271504
CPT
-
Packaging group
250
Unit
I.E.
Composition
Praeparatio cryodesiccata: factor VIII coagulationis humanus 250 U.I., corresp. Specific activity (albumin-corrected) 70 ± 30 U.I. pro proteina 1 mg, corresp. von Willebrand factor activity (VWF:CBA) ca. 38 U.I./ml. albuminum humanum, glycinum, lysini hydrochloridum 25 mg, natrii chloridum, natrii citras dihydricus, calcii chloridum dihydricum, pro vitro corresp. natrium ca. 9.8 mg. Solvens: aqua ad iniectabile, pro vitro corresp. in solutione recenter reconstituta 50 U.I./ml.

Articles (1)

Immunate S/D 250 I.E., Pulver und Lösungsmittel zur Herstellung einer Injektionslösung
Pulver
250
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Professional SmPC
Allemand
04/06/2026
Professional SmPC
Français
04/06/2026
Professional SmPC
Italien
04/06/2026

Detailed composition

Substance Quantity Type Category
aqua ad iniectabile
- Substance HNIDK
factor VIII coagulationis humanus
250.0 UI Substance Wirkstoff (Principe actif)
proteina
1.0 MG Substance WIZUS
albuminum humanum
- Substance HNIDK
glycinum
- Substance HNIDK
lysini hydrochloridum
25.0 MG Substance WIZUS
natrii chloridum
- Substance HNIDK
natrii citras dihydricus
- Substance HNIDK
calcii chloridum dihydricum
- Substance HNIDK
natrium
- Substance HBESI

Authorization holder

Takeda Pharma AG

8152 Opfikon

Authorization information

Swissmedic authorization number
52715
Drug name
Immunate S/D, Pulver und Lösungsmittel zur Herstellung einer Injektionslösung
Galenic form
LSPA
ATC Code
B02BD06
Authorization status
Z
Dispensation category
B
First authorization
24/08/1995
Authorization expiration date
31/12/9999
IT number
06.01.1.
Domain
Human medicine
Field of application
Hämophilie A (angeborener Faktor VIII-Mangel) Faktor VIII Mangel Prophylaxe und Therapie von Blutungen bei Hämophilie A und beim von Willebrand Syndrom

Packaging details

Description (FR)
IMMUNATE S/D subst sèche 250 UI cum solv flac
Description (DE)
IMMUNATE S/D Trockensub 250 IE cum Solv Durchstf
Market launch
01/01/2005
Narcotic (BTM)
No

Application methods

IV

Other packaging sizes

IMMUNATE S/D subst sèche 500 UI cum solv flac
500 IE
View
IMMUNATE S/D subst sèche 1000 UI cum solv flac
1000 IE
View
Buy us a coffee Explore the data